top of page

Biotech entrepreneurs share advice on navigating through today's uncertain times: "It's going to be okay"

blonca9
Oct 21
1 min read

MassBio CEO Kendalle Burlin O'Connell moderates a discussion with Normunity CEO Rachel Humphrey and Gallop Oncology CEO Luba Greenwood about how they are rising to today's challenges. Topics include the funding environment, motivating your team, storytelling, FDA engagement, and perseverance.

Chapters

Intro's – 0:52

The funding environment - 2:51

Motivating your team – 17:20

Storytelling – 28:17

Engagement with FDA – 39:51

Perseverance – 42:23

Advice for new entrepreneurs – 47:42

Recent Posts

See All

Science Explainer: Brain shuttle technologies have been in the news a lot lately. Natalie Ricciardi explains what you need to know about 1st and 2nd generation technologies in development.

Miami Oncology Summit: Medical Oncologist Dionysios Watson discusses the latest in lung and head & neck cancer, and his early stage research on next-gen immunotherapy

Miami Oncology Summit: Damian Green, Chief of Sylvester's Division of Transplantation and Cellular Therapy, discusses the latest in CAR-T and radiopharma

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate